American Trust Investment Advisors, LLC Abb Vie Inc. Transaction History

American Trust Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $286,251 - $433,992	-4,438 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $11,966 - $14,386	-190 Reduced 4.11%	4,438 $336,000
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $14,256 - $18,223	-217 Reduced 4.48%	4,628 $337,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $17,356 - $20,427	-225 Reduced 4.44%	4,845 $390,000
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $5,449 - $6,720	70 Added 1.4%	5,070 $467,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $13,336 - $14,826	150 Added 3.09%	5,000 $473,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $34,565 - $40,898	385 Added 8.62%	4,850 $449,000
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $12,986 - $14,240	-145 Reduced 3.15%	4,465 $432,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $322,008 - $411,304	4,610	4,610 $410,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of American Trust Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on American Trust Investment Advisors, LLC with notifications on news.